Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$524M |
| 2 |
Meta Platforms (Facebook)
META
|
+$458M |
| 3 |
Otis Worldwide
OTIS
|
+$345M |
| 4 |
T-Mobile US
TMUS
|
+$307M |
| 5 |
AbbVie
ABBV
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$878M |
| 2 |
RTN
Raytheon Company
RTN
|
+$537M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$435M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
Accenture
ACN
|
+$216M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.72% |
| 2 | Healthcare | 14.52% |
| 3 | Financials | 12.98% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARNA
851
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $54.3M | 0.01% |
862,476
+116,671
| +16% | +$6.42M |
|
852
Semtech
SMTC
$13B
| $54.2M | 0.01% |
1,037,506
-6,608
| -0.6% | -$309K |
|
853
ZTO Express
ZTO
$17.9B
| $54.2M | 0.01% |
1,481,735
+45,307
| +3% | +$1.44M |
|
|
JBGS
854
JBG SMITH
JBGS
$708M
| $54M | 0.01% |
1,827,581
-40,670
| -2% | -$1.26M |
|
|
SMAR
855
DELISTED
Smartsheet Inc.
SMAR
| $54M | 0.01% |
1,061,032
+90,952
| +9% | +$4.63M |
|
856
FTI Consulting
FCN
$4.18B
| $54M | 0.01% |
470,840
-108,391
| -19% | -$13.1M |
|
857
Enphase Energy
ENPH
$5.53B
| $53.9M | 0.01% |
1,133,800
-159,656
| -12% | -$7.63M |
|
858
Mercury Systems
MRCY
$6.52B
| $53.8M | 0.01% |
684,287
-149,094
| -18% | -$12.2M |
|
859
Cirrus Logic
CRUS
$6.26B
| $53.8M | 0.01% |
870,255
-165,577
| -16% | -$11.3M |
|
860
Axalta
AXTA
$8.17B
| $53.3M | 0.01% |
2,364,949
+49,356
| +2% | +$1.01M |
|
861
United Bankshares
UBSI
$6.62B
| $53.2M | 0.01% |
1,925,047
+440,386
| +30% | +$11.8M |
|
862
Teva Pharmaceuticals
TEVA
$41.2B
| $53.2M | 0.01% |
4,322,259
+36,558
| +0.9% | +$413K |
|
|
XLRN
863
DELISTED
Acceleron Pharma
XLRN
| $53.2M | 0.01% |
557,980
-124,865
| -18% | -$12M |
|
864
Graphic Packaging
GPK
$3.58B
| $53.1M | 0.01% |
3,795,200
-124,416
| -3% | -$1.67M |
|
|
TMX
865
DELISTED
Terminix Global Holdings, Inc.
TMX
| $52.8M | 0.01% |
1,479,065
-25,938
| -2% | -$800K |
|
|
LOGM
866
DELISTED
LogMein, Inc.
LOGM
| $52.7M | 0.01% |
622,213
+7,089
| +1% | +$601K |
|
867
Herbalife
HLF
$1.29B
| $52.7M | 0.01% |
1,170,524
-218,754
| -16% | -$8.5M |
|
868
New Oriental
EDU
$8.98B
| $52.7M | 0.01% |
406,923
+21,620
| +6% | +$2.63M |
|
|
DOC
869
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $52.7M | 0.01% |
3,006,381
+269,715
| +10% | +$4.4M |
|
870
Flowers Foods
FLO
$1.57B
| $52.5M | 0.01% |
2,347,880
-2,944
| -0.1% | -$66.3K |
|
871
UFP Industries
UFPI
$5.19B
| $52.5M | 0.01% |
1,059,622
+13,516
| +1% | +$575K |
|
872
Grand Canyon Education
LOPE
$3.98B
| $52.2M | 0.01% |
576,900
-5,770
| -1% | -$513K |
|
873
ManpowerGroup
MAN
$2.63B
| $52.2M | 0.01% |
759,162
-24,122
| -3% | -$1.65M |
|
874
Natera
NTRA
$46.4B
| $52.2M | 0.01% |
1,046,006
+61,222
| +6% | +$2.46M |
|
875
Black Hills Corp
BKH
$5.69B
| $52.1M | 0.01% |
919,421
+36,188
| +4% | +$2.19M |
|
Similar funds
Geode Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Geode Capital Management held 4,219 positions worth $467B, up 22% from $384B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q2 2020 filing shows 118 new, 2,550 increased, 1,055 reduced and 119 closed positions. Its largest new stake was Otis Worldwide: 6,650,358 shares worth $377M. The largest sale was Allergan plc, an estimated $878M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q2 2020 buy was Otis Worldwide: 6,650,358 shares worth $377M.
- Geode Capital Management added most to Amazon in Q2 2020, an estimated $524M increase.
- Geode Capital Management's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $435M.
- Geode Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $878M.
- Geode Capital Management's ten largest holdings make up 23% of its $467B portfolio in Q2 2020.
- Geode Capital Management opened 118 new positions and closed 119 in Q2 2020.
- Geode Capital Management's portfolio value rose 22% quarter-over-quarter to $467B.
Based on Geode Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.